Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of doxycycline intermediate

A doxycycline intermediate technology, applied in the field of preparation of doxycycline intermediates, can solve the problems of slow hydrogenation reaction rate, low selectivity, slow catalytic reaction rate, etc., to reduce reduction cost, increase conversion rate, increase selective effect

Inactive Publication Date: 2022-01-14
SHANDONG GUOBANG PHARMA +1
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The reduction reaction is often catalyzed by a heterogeneous catalyst supported by activated carbon with noble metals. The selectivity of the reduction process is low, and more β impurities are likely to be produced, generally at 5% to 10%. At the same time, the catalytic reaction rate is slow, the reaction conversion rate is low, and the remaining The raw material becomes an impurity that is difficult to be refined in the subsequent steps; in addition, the catalyst itself is expensive, the amount of feed is large and the preparation cost is high
In summary, the preparation process of doxycycline still has the problems of slow hydrogenation reaction rate, low selectivity, and high cost of heterogeneous catalysts used

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of doxycycline intermediate
  • Preparation method of doxycycline intermediate
  • Preparation method of doxycycline intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Preparation of reducing reagent

[0035] Add 100.05g of tetrahydrofuran into a 250ml reaction bottle, then add sodium borohydride at a mass ratio of 1:4, and then add anhydrous zinc chloride at one time (the mass ratio of anhydrous zinc chloride to sodium borohydride is 1: 3.5), filled with nitrogen, magnetically stirred for 10 hours, filtered to remove salt, and obtained a zinc borohydride solution with a mass concentration of 24.94%.

Embodiment 2

[0037] Preparation of reducing reagent

[0038] Add 100.05g of tetrahydrofuran to a 250ml reaction bottle, then add sodium borohydride at a mass ratio of 1:6, and then add anhydrous zinc chloride at one time (the mass ratio of anhydrous zinc chloride to sodium borohydride is 1: 4), filled with nitrogen, magnetically stirred and reacted for 14 hours, filtered to remove salt, and obtained a zinc borohydride solution with a mass concentration of 17.75%.

Embodiment 3

[0040] Preparation of reducing reagent

[0041] Add 100.05g of tetrahydrofuran to a 250ml reaction bottle, then add 20.03g of sodium borohydride, then add 64.96g of anhydrous zinc chloride at one time, fill with nitrogen, stir for 12 hours with magnetic force, filter to remove salt, and obtain a mass concentration of 19.89% Zinc borohydride solution.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of veterinary drugs, in particular to a preparation method of a doxycycline intermediate. The preparation method comprises the following steps: (1) uniformly mixing metacycline p-toluenesulfonate and absolute ethyl alcohol in proportion, dropwise adding concentrated hydrochloric acid, carrying out stirring and uniform mixing, and controlling the temperature of a reaction system at 10-35 DEG C; (2) dropwise adding a zinc borohydride solution into a reaction system obtained in the step (1), and controlling heat preservation reaction time to be 2-5 hours to obtain a feed liquid for later use; and (3) dropwise adding an aqueous sulfosalicylic acid solution into the feed liquid obtained in the step (2) according to a mass ratio of (0.7-1.5): 1 under the condition of 20-30 DEG C, carrying out heat preservation reaction for 4-6 hours, conducting cooling to 0-10 DEG C, and carrying out filtering to obtain the doxycycline sulfosalicylate. By utilizing the preparation method, the conversion rate and selectivity of raw materials and the yield of doxycycline p-toluenesulfonate are improved, and reduction cost and safety risks in a reaction process are reduced.

Description

technical field [0001] The invention relates to the technical field of veterinary medicine, in particular to a preparation method of a doxycycline intermediate. Background technique [0002] Doxycycline is a tetracyclic antibiotic with broad-spectrum antibacterial activity, showing good clinical effects. At present, the preparation method of doxycycline is as follows: starting from oxytetracycline, 11α-chloro-6-methine oxytetracycline p-toluenesulfonate is obtained through chlorination and dehydration, and then through one-step or two-step hydrogenation method Replace the chlorine atom of 11α, and reduce the carbon-carbon double bond at position 6 to produce doxycycline p-toluenesulfonate, and finally refine it into a salt to obtain doxycycline, in which the intermediate of hydrogenation process is metacycline p-toluenesulfonate. The 6th position of doxycycline is a chiral carbon atom, so the hydrogenation step will produce two isomers, α and β, and the biological activity...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C231/12C07C237/26C07C303/32C07C309/30C07C309/60
CPCC07C231/12C07C303/32C07C2603/46C07C237/26C07C309/30C07C309/60
Inventor 李芳于童熊历强郭兴龙王伟宏岳伟
Owner SHANDONG GUOBANG PHARMA